NCT02086071View on ClinicalTrials.gov

Feasibility of re Biopsies at Progression

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

May 31, 2013

Conditions
Lung Cancer
Interventions
PROCEDURE

re biopsy

re biopsy depending on the location of the pathology

Trial Locations (9)

13274

Site 06, Marseille

14000

Centre François Baclesse, Caen

29200

Centre Hospitalier du Morvan, Brest

35033

Site 20, Rennes

49033

Centre Hospitalier Universitaire, Angers

75012

Hospital Saint Antoine, Paris

78200

Site 25, Mantes-la-Jolie

87042

Hospital du Cluzeau, Limoges

05000

Site 04, Gap

All Listed Sponsors
lead

Groupe Francais De Pneumo-Cancerologie

OTHER

NCT02086071 - Feasibility of re Biopsies at Progression | Biotech Hunter | Biotech Hunter